标题
Emerging drugs for high-grade osteosarcoma
作者
关键词
-
出版物
EXPERT OPINION ON EMERGING DRUGS
Volume 15, Issue 4, Pages 615-634
出版商
Informa Healthcare
发表日期
2010-08-09
DOI
10.1517/14728214.2010.505603
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Physiological and Oncogenic Aurora-A Pathway
- (2012) Toshiaki SAEKI et al. International Journal of Biological Sciences
- NVP-BEZ235 as a New Therapeutic Option for Sarcomas
- (2010) M. C. Manara et al. CLINICAL CANCER RESEARCH
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- Role of Glutathione Transferases in the Mechanism of Brostallicin Activation
- (2009) Silvia Pezzola et al. BIOCHEMISTRY
- Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma
- (2009) Ayesha Abdeen et al. CANCER
- Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma
- (2009) Alexander J. Chou et al. CANCER
- The Insulin-like Growth Factor-1 Receptor-Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma
- (2009) R. T. Kurmasheva et al. CANCER RESEARCH
- Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
- (2009) S. Avnet et al. CANCER RESEARCH
- Functional genome screen for therapeutic targets of osteosarcoma
- (2009) Umio Yamaguchi et al. CANCER SCIENCE
- A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors
- (2009) R. B. Cohen et al. CLINICAL CANCER RESEARCH
- Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo
- (2009) P. Hingorani et al. CLINICAL CANCER RESEARCH
- Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model
- (2009) A. Labrinidis et al. CLINICAL CANCER RESEARCH
- Targeted Therapies in Bone Sarcomas
- (2009) K. Scotlandi et al. CURRENT CANCER DRUG TARGETS
- Novel agents in development for pediatric sarcomas
- (2009) Dennis PM Hughes CURRENT OPINION IN ONCOLOGY
- Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
- (2009) I. Vergote et al. EUROPEAN JOURNAL OF CANCER
- Prognostic factors and outcomes for osteosarcoma: An international collaboration
- (2009) Emilios E. Pakos et al. EUROPEAN JOURNAL OF CANCER
- Novel therapeutic agents for osteosarcoma
- (2009) Kathleen O’Day et al. Expert Review of Anticancer Therapy
- Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
- (2009) Paul A Meyers Expert Review of Anticancer Therapy
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors
- (2009) Neeltje Steeghs et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer
- (2009) Lecia V. Sequist et al. Journal of Thoracic Oncology
- ABC Transporters as Potential Targets for Modulation of Drug Resistance
- (2009) L. Gatti et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
- (2009) Ymera Pignochino et al. Molecular Cancer
- The Role of IGF-1R in Pediatric Malignancies
- (2009) S. Y. Kim et al. ONCOLOGIST
- The role of interferons in the treatment of osteosarcoma
- (2009) Jeremy Whelan et al. PEDIATRIC BLOOD & CANCER
- Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma
- (2008) I. Scionti et al. ANNALS OF ONCOLOGY
- Autophagy: A Novel Mechanism of Synergistic Cytotoxicity between Doxorubicin and Roscovitine in a Sarcoma Model
- (2008) L. A. Lambert et al. CANCER RESEARCH
- Overcoming Glutathione S-Transferase P1-Related Cisplatin Resistance in Osteosarcoma
- (2008) M. Pasello et al. CANCER RESEARCH
- The role of mTOR in the management of solid tumors: An overview
- (2008) Alex S. Strimpakos et al. CANCER TREATMENT REVIEWS
- Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro
- (2008) Patrick J. Messerschmitt et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma)
- (2008) Pete Anderson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines
- (2008) Claudia M. Hattinger et al. GENES CHROMOSOMES & CANCER
- Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
- (2008) B. Ory et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies
- (2008) Monica M. Mita et al. JOURNAL OF CLINICAL ONCOLOGY
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
- (2008) Paul A. Meyers et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway
- (2008) T. Akiyama et al. MOLECULAR CANCER THERAPEUTICS
- Therapy for Osteosarcoma
- (2008) Alexander J Chou et al. PEDIATRIC DRUGS
- Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program
- (2007) John M. Maris et al. PEDIATRIC BLOOD & CANCER
- Initial testing of dasatinib by the pediatric preclinical testing program
- (2007) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search